pimecrolimus
Ligand Summary
an ascomycin derivative; mechanism of action involves calcineurin inhibition, blockage of T cell activation, blocking signal transduction pathways in T cells, and inhibition of the synthesis of inflammatory cytokines, specifically Th1- and Th2-type cytokines
UNII: 7KYV510875
PubChem: 6509979
Guide to Pharmacology: 6783
ChEMBL: CHEMBL1200686
DrugCentral: 2168
LyCHI: FAVP42HK5U5Z
Target Activities
2 Activities
Items per page:
10
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
Kd | INHIBITOR | |||||